Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
Post# of 27
Next 10
Reply Private New
Public Reply Private Reply New Post
Replies (1)
Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

lecorb

Send PM
Followers 24
Posts 1195
Boards Moderated 0
Alias Born 04/04/2012

FREE
NAUT REPORT

lecorb

Re: findit post# 15

Thursday, 08/05/2021 4:25:19 PM

Thursday, August 05, 2021 4:25:19 PM

Post# of 27
NAUTILUS BIOTECHNOLOGY (NASDAQ NAUT) INSTITUTIONAL BUYING
7/31/2021 Amazon com Inc Shares: 1,457,055 $14.72M 3.9% N/A 8.720% Stake.
MarketBeat!

NAUTILUS BIOTECHNOLOGY (NASDAQ:NAUT) PRICE TARGET AND CONSENSUS RATING
2 Wall Street analysts have issued ratings and price targets for Nautilus Biotechnology in the last 12 months. Their average twelve-month price target is $11.50, predicting that the stock has a possible upside of 34.66%. The high price target for NAUT is $13.00 and the low price target for NAUT is $10.00. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Buy."

8/4/2021 The Goldman Sachs Group Initiated Coverage Neutral $10.00
7/13/2021 Jefferies Financial Group Initiated Coverage Buy $13.00

MarketBeat!
Public Reply Private Reply New Post
Replies (1)
Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NAUT News
More NAUT News
InvestorsHub NewsWire

FEATURED UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • Jan 26, 2023 7:21 AM

IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM

Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM

Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM

B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM

Hebrew University' Yissum and Israeli Biotech Clearmind Medicine's Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023 • CMND • Jan 25, 2023 8:48 AM

Sika Health and Electromedical Announce Partnership Enabling HSA/FSA Payments on Electromedical eCommerce Site • EMED • Jan 25, 2023 7:09 AM

AgriFORCE Announces Binding Letter of Intent to Acquire Berry People LLC, Further Strengthening its Brands Division • AGRI • Jan 24, 2023 9:00 AM

Green Battery Minerals creates lithium-ion battery using esg-friendly graphene technology and enters into memorandum of understanding with graphene star, a uk graphene producer • GEM • Jan 23, 2023 1:41 PM

Global Arena Holding Updates Shareholders on Subsidiary Company Global Election Services • GAHC • Jan 23, 2023 10:02 AM

Kona Gold Beverage, Inc Announces 2023 Revenue Projections • KGKG • Jan 23, 2023 9:00 AM

ARway The Spatial Computing platform for The Metaverse Announces Multiple Pilot Projects for AR Wayfinding • ARWY • Jan 20, 2023 9:35 AM

Rodedawg International Industries, Inc. (OTC: RWGI) Provides Shareholder Updates • RWGI • Jan 20, 2023 8:30 AM

HealthLynked Announces Sale of ACO Health Partners • HLYK • Jan 20, 2023 8:00 AM

UCASU acquires $3M cannabis property and aims at $1M gross profit for 2023 • UCASU • Jan 19, 2023 10:29 AM

Start posting your company's news
Only $200 per official company press release!